Clinical and electrophysiological features of the patients
| Patient no | Sex/Age | Electrophysiological classification | FNCV | CSF anti-r-VacA ab | CSF IgG (mg/dl) | Serum anti-H.p. ab | Serum anti-r-VacA ab | Brain stem signs | Anti-ganglioside ab |
|---|---|---|---|---|---|---|---|---|---|
| CSF, cerebrospinal fluid; ab, antibody; H.p., Helicobacter pylori; NE, not examined; *: AMRAD Operation Pty LTD (Australia). | |||||||||
| 1 | M/78 | AIDP | ND | Positive | 19.7 | 3.9 | NE | None | NE |
| 2 | M/77 | AIDP | NE | Positive | 8 | 4 | NE | None | Negative |
| 3 | M/48 | AIDP | ↓Latency | Positive | 8.8 | 5.5 | Positive | None | GM1b IgG, M. |
| GalNAc GD1a IgG, M | |||||||||
| 4 | F/54 | AIDP | NE | Positive | 4.8 | 2.9 | NE | Facial palsy Abducens palsy | NE |
| 5 | M/72 | AIDP | ↓Latency | Positive | 8.8 | 5.6 | Positive | None | Negative |
| 6 | F/56 | AIDP | Normal | Positive | 27.8 | NE | Positive | None | GM1 IgG |
| 7 | M/56 | Inexcitable | NE | Negative | 3.6 | 4 | NE | None | NE |
| 8 | M/44 | AMAN | Normal | Negative | 21.7 | NE | NE | None | NE |
| 9 | M/48 | AMAN | NE | Negative | 11.4 | 309 U/ml (positive)* | NE | None | NE |
| 10 | M/51 | AIDP | Normal | Negative | 2.6 | 3 | NE | None | GM1 IgG |
| 11 | M/33 | AMAN | Normal | Negative | 30.6 | Negative | NE | Facial palsy Bulbar signs | Negative |
| 12 | M/40 | AMAN | Normal | Negative | 12.3 | Negative | NE | None | Negative |
| 13 | F/20 | AIDP | Normal | Negative | 8.6 | Negative | NE | None | NE |